Soothion Psoriasis And Seborrheic Dermatitis Formula
Product Images NDC 69031-004

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Soothion Psoriasis And Seborrheic Dermatitis Formula (NDC 69031-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Electrolyzed Innovations, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Soothion Psoriasis Label (Soothion Psoriasis Label)

This section provides information related to drug facts and includes details on the active ingredients in the medication. The medicine aims to control and eliminate recurrence of skin redness, flaking, scaling associated with psoriasis and seborrheic dermatitis. The product is safe for external use only, but it's essential to consult a doctor if the area of application is extensive or there is visible eye contact. The inactive components of the medication include chestnut, montana, calonduls, and soiva seed oil. The product is designed to relieve symptoms such as itching, irritation, flaking, redness, and scaling. The package contains 8oz (226g) of the medication, and this product is manufactured in the USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.